The Observational Study of Chronic Myeloid Leukemia Patients in Chronic Phase with Resistance or Intolerance to Preceding TKI in Japa
Not Applicable
- Conditions
- Chronic Myeloid Leukemia
- Registration Number
- JPRN-UMIN000003582
- Lead Sponsor
- The Japanese Society of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients previously treated with any investigational drug for CML. 2)Women with confirmed or potential pregnancy, nursing mothers, and male or female patients who wish to have a child during the study period. 3)Patients with a history of allergy to imatinib, nilotinib or dasatinib. 4)Patients with any concomitant illness that contraindicates use of imatinib, nilotinib or dasatinib. 5)Patients with any other condition that, in the investigator's opinion, disqualifies them for inclusion in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method